• 13 March 2018

    Sarepta to request FDA accelerated approval for DMD drug

    Sarepta Therapeutics has announced its plans to submit a New Drug Application (NDA) for accelerated approval of its drug golodirsen (SRP-4053), a treatment for the neuromuscular disorder Duchenne Muscular Dystrophy...

  • 16 February 2018

    Prostate cancer drug given approval by the FDA

    The US Food and Drug Administration (FDA) has approved Johnson & Johnson’s (J&J) next-generation prostate cancer drug apalutamide, to be sold under the brand name Erleada.

  • 10 April 2017

    NHS’ anti-HIV drug PrEP approved in Scotland, UK

    The Scottish Medicines Consortium (SMC), UK, has approved the supply of Emtricitabine / tenofovir disoproxil (Truvada) by the National Health Service (NHS) to prevent HIV in the nation.